Onychomycosis - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

As per Global Insight services' assessment, about 13 prominent pharma and biotech giants are working on 13 drugs in the Onychomycosis - pipeline landscape globally. Onychomycosis Pipeline Insight, 2023" report by Global Insight Services provides a comprehensive analysis of the ongoing clinical development activities and growth prospect.

Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies: https://www.globalinsightservices.com/request-sample/GIS31243

Onychomycosis is a fungal infection of the nail plate, nail bed, or both. Infection may be distal subungual, with nail thickening and yellowing and accumulation of keratin and debris underneath the nail, proximal subungual or white superficial with spreading of chalky white scale beneath the nail surface.

Onychomycosis is caused by 3 main classes of fungi: dermatophytes, yeasts, and non-dermatophyte molds. Dermatophytes are by far the most common cause of onychomycosis. Onychomycosis can cause pain, discomfort, and disfigurement. Onychomycosis is highly prevalent, particularly among older men and patients with compromised distal circulation, nail dystrophies, and/or tinea pedis.

Read more about Onychomycosis Pipeline Insight here: https://www.globalinsightservices.com/reports/onychomycosis-drug-pipeline-landscape/

Report Highlights:

Global Insight Service's, Onychomycosis - Drug Pipeline Landscape, 2023 report provides an overview of the Onychomycosis pipeline drugs. This report covers detailed insights on Onychomycosis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Onychomycosis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology:

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope:

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

Major pharmaceutical companies are involved in the development of potential drug candidates to improve the Onychomycosis treatment such as Efinaconazole, MOB015, BB2603 and others. Key players involved in the development of therapies to treat Onychomycosis are Almirall, AmtixBio Co Ltd, Blueberry Therapeutics, Moberg Pharma AB, NovaBiotics and others. Two drugs are under late-stage pre-registration, seven drugs are in Phase II clinical trials and two drugs are in Phase I clinical trials and some other drugs are under preclinical stages of development.

For In-Depth Competitive Analysis, Purchase this Report: https://www.globalinsightservices.com/checkout/single_user/GIS31243

Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like:

- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.